Good DREAMM-1 Data Keeps GSK On Track For Multiple Myeloma Filing This Year

 
• By Sten Stovall
Stethoscope
GSK Hopes '916 will reach the MM market by 2020 • Source: Shutterstock

More from Clinical Trials

More from R&D